Group 1 - The core point of the article is that Guichuang Tongqiao Medical Technology Co., Ltd. has signed an agreement to acquire shares of Optimed Medizinische Instrumente GmbH in a phased manner, with an option to acquire the remaining shares in the future [2][3] - Optimed, established in 1996, specializes in the research, production, and global sales of minimally invasive vascular and urological medical devices, with a sales and service network covering over 70 countries [2] - The acquisition aims to integrate the commercialization platforms of both companies, enhancing their sales, marketing, and customer service systems to provide high-quality and affordable medical solutions to more patients and doctors [2] Group 2 - The chairman and CEO of Guichuang Tongqiao stated that this acquisition is a significant milestone in the company's internationalization strategy, aiming to strengthen its presence in the European and global markets [3] - The collaboration with Optimed is expected to leverage complementary advantages in product portfolio, production operations, and commercialization platforms, creating an integrated operational platform across China and Europe [3] - The partnership will accelerate clinical trials, post-market follow-up research, and commercialization of related products in international markets, benefiting global healthcare providers and patients [2][3]
归创通桥：拟战略收购德国Optimed公司 拓展血管介入全球制造与商业化版图